Achalasia Clinical Trial
Official title:
Peroral Endoscopic Myotomy (POEM) for the Treatment of Esophageal Achalasia: Long vs Short Myotomy. Prospective Randomized Controlled Study
Per-Oral Endoscopic Myotomy (POEM) is increasingly used for the treatment of achalasia. In
published series, a 12cm-POEM is usually performed. Surgical myotomy is typically shorter
(8cm). The clinical efficacy of both procedure is comparable.
This study intends to investigate if clinical outcomes of POEM depends on the length of
esophageal myotomy, in patients with classic-type achalasia (type I and type II according to
Chicago Classification)
Status | Recruiting |
Enrollment | 200 |
Est. completion date | January 1, 2022 |
Est. primary completion date | January 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Diagnosis of achalasia (type I and II) 2. Age > 18 3. Signed informed consent 4. Patient accepts to undergo scheduled follow-up after POEM 5. Eckardt score > 3 6. ASA I-II-III Exclusion Criteria: 1. Prior surgical treatment of achalasia (previous endoscopic balloon dilation or botox injection ARE NOT exclusion criteria) 2. Pregnancy or nursing 3. Current alcohol or drug addiction. 4. Mentally retarded or emotionally unstable, or exhibits psychological characteristics which, in the opinion of the investigator make the subject a poor candidate for this study. 5. Severe congenital or acquired coagulopathy or INR > 1.6 6. Participating in another ongoing clinical trial in which concomitant diagnosis or therapeutic intervention would adversely affect the integrity of the clinical trial. 7. Hepatic cirrhosis w/ or w/o portal hypertension w/ or w/o esophageal varices 8. Eosinophilic esophagitis or Barrett Esophagus 9. Esophageal Strictures |
Country | Name | City | State |
---|---|---|---|
Italy | Fondazione Policlinico Universitario Agostino Gemelli | Roma | RM |
Lead Sponsor | Collaborator |
---|---|
Catholic University of the Sacred Heart |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Non-inferiority of a Short-POEM compared to a Long-POEM | Treatment success, defined as an Eckard score = 3. The Eckardt score is a clinical score for evaluating the severity of achalasia-related symptoms. Eckardt score varies between 0 and 12. Questions are asked about the frequency of dysphagia, regurgitation and retrosternal pressure sensation. Depending on whether any of these symptom occurrs, never, occasionally, daily or with each meal, a symptom score between 0 and 3 is applied. In addition a symptom score of 0-3 is assigned to the degree of weight loss (0 - No weight loss; 1 - weight loss < 5Kg, 2 - weight loss between 5 and 10Kg, 3- weight loss > 10Kg). Each symptom score (dysphagia, regurgitation, retrosternal pressure, and wieight loss) is summed to the other. Thus, a completely asymptomatic patient has a score of 0 and the most severely affected patient had a maximum score of 12. |
2 years | |
Secondary | Basal Lower Esophageal Sphincter (LES) pressure | Basal LES pressure on esophageal manometry after Short-POEM compared to Long-POEM | Before POEM, 6 months and 2 years after the procedure | |
Secondary | 4-second Integrated Relaxation Pressure (4sIRP) | 4sIRP on esophageal manometry after Short-POEM compared to Long-POEM | Before POEM, 6 months and 2 years after the procedure | |
Secondary | Side effects and complications | Incidence of side effect and complications after Short-POEM compared to Long-POEM | Baseline to 2 years | |
Secondary | Gastro-Esophageal Reflux (GER) symptom assessment | GerdQ questionnaire will be used to evaluate and compare Gastoesophageal reflux symptoms in the two groups. GerdQ is a 6-item, validated, easy to use questionnaire. The GerdQ questionnaire asks patients to score the number of days with symptoms and use of over-the-counter (OTC) medications during the previous 7 days. It uses a four graded Likert scale (0-3) to score the frequency of four positive predictors of GERD (heartburn, regurgitation, sleep disturbance due to reflux symptoms or use of over-the-counter (OTC) medications for reflux symptoms) and a reversed Likert scale (3-0) for two negative predictors of GERD (epigastric pain and nausea) giving a total GerdQ score range of 0-18. The sleep disturbance and use of OTC medication are also used for assessment of the impact of GERD, giving a separate 'impact score' ranging from 0 to 6 |
baseline, 6 months and 2 years after POEM | |
Secondary | Esophageal pH-monitoring study | patients will undergo esophageal pH-monitoring study during the follow-up. DeMeester score will be used for the diagnosis of GERD. DeMeester score is a composite score based on 6 parameters (scored in comparison to mean values in normal subjects for each category below): Supine reflux, Upright reflux, Total reflux, Number of episodes, Number of episodes longer than 5 min, Longest episode. A score of >14.72 shows significant reflux. Prevalence of GERD will be compared in the two study groups |
6 months after POEM | |
Secondary | Operating time | The duration of the endoscopic procedures for each patients will be calculated, in minutes, since the mucosal incision until the endoscopic closure of the mucosal entry with the last endoscopic clip. The average duration of the procedure in the Short-POEM group will be compared wth the dureation of the procedures in the Long-POEM-groups |
During the endoscopic procedure | |
Secondary | Quality of life | Improvement of quality of life after Short-POEM compared to Long-POEM, assessed by using the SF-36 questionnaires' scores The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. The eight sections are: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health |
baseline, 6 months and 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01399476 -
Endoscopic Myotomy of the Lower Esophageal Sphincter for Achalasia
|
N/A | |
Recruiting |
NCT05326113 -
The Effect of Physiotherapy on Post POEM Reflux
|
N/A | |
Recruiting |
NCT06044155 -
redoPOEM : Failure of a First POEM
|
||
Recruiting |
NCT02989883 -
Clinical Outcomes of Peroral Endoscopic Myotomy
|
N/A | |
Terminated |
NCT02606578 -
Achalasia Patient Reported Outcomes
|
||
Recruiting |
NCT01793922 -
POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)
|
N/A | |
Recruiting |
NCT01302288 -
Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia
|
Phase 2 | |
Terminated |
NCT03875365 -
Institutional Outcome Data From Per-oral Plication of the Esophagus
|
||
Enrolling by invitation |
NCT02770859 -
Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository
|
||
Recruiting |
NCT05905016 -
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
|
||
Completed |
NCT01692106 -
A Clinical Study of Per Oral Endoscopic Myotomy (POEM) in Patients Suffering From Achalasia
|
N/A | |
Completed |
NCT01405469 -
Endoscopic Peroral Myotomy for Treatment of Achalasia
|
N/A | |
Completed |
NCT01402518 -
Per-Oral Endoscopic Myotomy
|
||
Not yet recruiting |
NCT00790465 -
Efficacy of Dark Chocolate in Achalasia Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT01799967 -
Minimally Invasive Surgery of the Gastro-esophageal Junction
|
||
Terminated |
NCT00604942 -
vMII for Measurement of Oesophageal Bolus Transport and Reflux
|
N/A | |
Recruiting |
NCT06405412 -
Effects of Malnutrition on Respiratory and Renal Functions in Patients Undergoing Peroral Endoscopic Myotomy (POEM)
|
N/A | |
Not yet recruiting |
NCT06042127 -
POEM-F for Achalasia International Study
|
N/A | |
Completed |
NCT04752670 -
ConMed Beamer Study
|
||
Completed |
NCT02314741 -
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility
|
N/A |